Corrigendum

Area of Science:

• Cardiology
• Pharmacology
• Clinical Practice Guidelines

Background:

• Antithrombotic agents are crucial for preventing thromboembolic events.
• Guidelines exist for the use of double and triple antithrombotic combinations.
• Previous research assessed adherence to these guidelines.

Purpose of the Study:

• To correct errors in a prior publication regarding adherence to antithrombotic prescribing guidelines.
• To ensure accurate reporting of prescribing patterns for dual and triple antithrombotic therapy.

Main Methods:

• The original study likely involved retrospective analysis of prescribing data.
• This corrigendum involves reviewing and amending the original findings.
• Specific details of the original methodology are referenced for correction.

Main Results:

• The corrigendum identifies and rectifies specific inaccuracies in the original study's data or interpretation.
• Corrected adherence rates or conclusions regarding guideline compliance are presented.
• The impact of the corrections on the overall findings is clarified.

Conclusions:

• Accurate reporting of adherence to antithrombotic prescribing guidelines is essential for patient safety.
• This correction ensures a more reliable understanding of clinical practice.
• Proper use of antithrombotic combinations remains a key area for quality improvement.